Silverback Therapeutics shares owned by OrbiMed Advisors
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by OrbiMed Advisors
from 13F filings
Historical chart of OrbiMed Advisors investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by OrbiMed Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $83M | 8.3M | 10.05 |
| 2025-06-30 | $145M | 8.3M | 17.45 |
| 2025-03-31 | $104M | 8.3M | 12.58 |
| 2024-12-31 | $87M | 8.3M | 10.55 |
| 2024-09-30 | $120M | 8.3M | 14.50 |
| 2024-06-30 | $79M | 9.2M | 8.51 |
| 2024-03-31 | $94M | 9.2M | 10.22 |
| 2023-12-31 | $51M | 9.2M | 5.48 |
| 2023-09-30 | $35M | 9.2M | 3.78 |
| 2023-06-30 | $59M | 8.7M | 6.70 |
| 2023-03-31 | $57M | 8.7M | 6.51 |
| 2022-12-31 | $75M | 8.7M | 8.53 |
| 2022-09-30 | $46M | 8.7M | 5.28 |
| 2022-06-30 | $37M | 8.7M | 4.24 |
| 2022-03-31 | $31M | 8.7M | 3.51 |
| 2021-12-31 | $58M | 8.7M | 6.66 |
| 2021-09-30 | $87M | 8.7M | 9.98 |
| 2021-06-30 | $270M | 8.7M | 30.89 |
| 2021-03-31 | $381M | 8.7M | 43.63 |
| 2020-12-31 | $405M | 8.7M | 46.34 |